Reproductive Health News

Telemedicine medication abortion services in primary care were well received by patients thanks to clear communication and previously established relationships, researchers found.

Menarche after the age of 14 years, or going through menopause before 45 years of age, are among the hormonal and reproductive factors that increase the risk for rheumatoid arthritis, according to data published in RMD Open.

There were no racial or ethnic disparities linked to neuraxial catheter placement for women undergoing cesarean delivery, despite disparities in general anesthesia rates continuing to exist, researchers reported in JAMA Network Open.

Twin birth rates rose with increasing prepregnancy BMI, and approximately 25% of the association can be explained by assisted reproductive technology use, according to study results published in JAMA Network Open.

Risks for adverse outcomes associated with COVID-19 at delivery stayed high during the omicron variant window, despite possible immunity from previous SARS-CoV-2 infection, vaccination or testing differences, researchers reported.

Based on interviews with 54 self-selected OB/GYNs, researchers reported in JAMA Network Open that OB/GYNs experienced “deep and pervasive” impacts from state abortion bans on workforce sustainability, physician health and patient outcomes.

In U.S. states with strong paid family and medical leave, there was a greater likelihood of breastfeeding and lower odds of postpartum depression symptoms, with stronger associations among those with Medicaid, researchers reported.

There was a significant increase in the use of long-acting reversible contraception among adolescents after the AAP recommended it almost a decade ago, according to findings published in JAMA Pediatrics.

Higher serum estradiol levels in early pregnancy were associated with increased risk for preeclampsia, particularly after frozen embryo transfer cycles, researchers reported in Frontiers in Endocrinology.

Women with poor ovarian response to stimulation had higher likelihood of using frozen oocytes after planned cryopreservation vs. women normal response, particularly among women aged 30 to 39 years, according to cohort study results.